Clinical Trials Logo

Clinical Trial Summary

Purpose: Most children and adolescents with chronic kidney disease (CKD) have much less physical endurance than their age matched peers, are at high risk for premature cardiovascular disease, and have a poor self image in part due to limited peer contact. Sustained exercise in adults with CKD improves endurance and decreases cardiovascular risk. Minimal data exists in pediatric CKD patients. This study will show whether 12 days of increased exercise at a summer camp will improve endurance as measured by the distance walked in 6 minutes and self concept as measured by a short standardized questionaire (Harter scale). The study will occur at the Frost Valley YMCA in the Catskills where in 2, 12 day sessions a total of 25-30 kidney campers are mainstreamed in the general camp population of about 500. Mainstreaming means that the kidney camper will live in a cabin with 8-10 age matched peers and participate as much as possible in all camp activities with their bunkmates. The kidney program at Frost Valley provides hemo and peritoneal dialysis, as well as caring for children with less advanced CKD and post transplant. Participants will have activity measured before and duringcamp by wearing a pedometer. The distance walked in 6 minutes (a 6 minutewalk test) will be measured at onset and completion of the 12 day camp experience. A standardized questionaire on self concept will also be administered at the onset and completion of camp.


Clinical Trial Description

BACKGROUND: Children and adolescents with CKD have high rates of hospitalization, and those with End-Stage Renal Disease (ESRD) have a remaining life expectancy of about 20 years with increased risk of premature death due to cardiovascular disease. Most have much less physical endurance than their age matched peers with the degree of underperformance loosely correlated with the severity of their renal disease. Cardiovascular disease, chronic inflammation, anemia, low muscular strength and/or bone disease are among the factors considered responsible for the poor physical conditioning. However, the investigators hypothesize that the most important cause is inactivity caused by a varying combination of parental 'protection', limited or poor peer inaction, and patient choice. In addition, children who require chronic hemodialysis have an enforced 10-14 hours weekly of enforced inactivity. Cardiovascular morbidity is commonly associated with chronic kidney disease and physical endurance is a measure of cardiovascular health. In addition many children with chronic kidney disease demonstrate poor self-concept, in part related to their lack of physical endurance and limited peer contact. Multiple studies of adults with chronic kidney disease have documented poor physical conditioning and function. Over the past decade, many studies have demonstrated in adults with CKD a significant benefit of regular exercise on physical fitness, walking capacity, blood pressure, and health related quality of life. Several small studies have shown a modest improvement in children and adolescents with CKD but these studies have had high drop-out rates and problematic compliance. A 2012 study by Akber et al using pedometer measurements showed that over a 7 day period, children, adolescents, and young adults with CKD (n=44) on average walked about 50% less than expected using data collected by NHANES as a standard. Females walked less than males and older children were less active than younger children. On a 6 minute walk test, males scored < 2 standard deviation below the expected mean and females <4 standard deviation below the mean. There was no measured difference between stage of CKD, dialysis, or transplant status. In 1975 the Ruth Gottscho Kidney Foundation partnered with the Albert Einstein College of Medicine and the Frost Valley YMCA to develop the first summer camp program capable of performing hemodialysis and caring for children with chronic kidney disease. One of the guiding principles of this program is that kidney campers (as well as some children with other chronic illnesses) are mainstreamed in with the general camp population and participate in the same activities as their age matched peers. Each summer, there are 4 two week camp session with about 500 campers attending each session. The program has run each summer since 1975, and the enrollment of kidney campers has varied from 25 to 50 each summer. The Frost Valley YMCA is located in the Catskill Mountains approximately 120 miles from New York City and is spread over about 2000 acres. Informal observation of the kidney campers indicates that many show improved physical endurance during their camp stay, and a study done early in the program's history demonstrated an improved self-esteem. , A study using the Piers Harris test of self-concept evaluated 24 chronic dialysis children during the Summer of 1976 and compared them to 76 regular campers. On arrival at camp the dialysis campers had a lower self-concept than the regular campers (P<.01). The same children were evaluated at the end of camp. Both groups improved their self-concept (P<0.02) but the dialysis campers showed greater improvement. (P<0.01) This study was presented at the 1977 Clinical Dialysis and Transplant Forum. The investigators hypothesize that during their time at camp the kidney campers will improve their physical endurance and their self-concept; which will be assessed objectively through physical fitness/function and psychometric assessments. The investigators hope to do this in a way that interferes as little as possible with the camp experience yet is educational and fun for the kidney campers and their peers. The ultimate objective of this pilot study is to increase awareness that children with CKD should be physically active, can enjoy being part of a program with their peers, and may benefit physically and mentally from it. METHODS: This pilot study designed in close collaboration between the UNC Kidney Center and the UNC Department of Exercise Science and will occur during the first two 12 day camp sessions at the Frost Valley YMCA during the Summer of 2016. Campers range in age from 8 to 17 years. Each kidney camper and age matched healthy controls (bunkmates) will be provided with a pedometer before camp arrival and will be asked to wear it throughout each day in the week before camp in order to record their physical activity level. Participants will also be asked to record screen time during the week prior to beginning the camp. Participants will be asked to wear the pedometer during their camp stay, except during waterfront activities, and the data recorded. The investigators hope to enroll all kidney campers (estimate 25-40 individuals) and approximately 70-100 control campers. The Omron 321 pedometer was chosen because it retains seven-days of data, is inexpensive, and has been previously shown to be a valid and reliable indicator of physical activity. On the day of, or the first day after camp arrival, each kidney camper along with his/her bunkmates will be asked to complete a 6 minute walk test (6MWT). A standardized chart to self-report their perceived exertion at the end of the walk will be used. Pulse upon completion of the 6MWT and 1 minute later will be measured. Each child will wear a portable pulse oximeter during the walk. The investigators hypothesize that the kidney campers will increase their activity at camp compared to their activity at home as measured by the pedometer, and also that they will be able to ambulate further as measured by the 6MWT with less perceived exertion and possibly lower post 6MWT pulse rate at the end of the camp session as compared to the beginning of camp. The 6MWT test was chosen as the primary test measurement in consultation with the Exercise Science Department faculty and camp administrative staff as there is considerable normative data in healthy children, it is non-invasive, and its administration can easily fit into the camp program. Having the kidney campers participate with their bunkmates in the 6MWT will provide motivation for campers to perform at as high a level as possible, yet not single the kidney campers out as special or specifically as research subjects. Research data will be collected only for those campers for whom consent/assent has been obtained. Similarly, data for the control campers will be instructive as to whether a relatively short period of increased activity (12 days) will allow measured changes in their 6MWT. In order to be time efficient and fit in with the camp environment, rather than the standard 6MWT which is classically done in a hallway between 2 cones separated by 20 meters, the campers will walk (not run) along the camp circle from approximately the laundry area to Biscuit Hall (modified 6MWT). This is a relatively level paved path (net elevation rise ~15 feet) about 1500 feet in distance and is estimated to take the average camper about 6 minutes. Any who reach Biscuit Hall earlier, will do laps around Biscuit until the 6 minutes is up. The course will be carefully measured and marked so that distances achieved will be accurately ascertained. The 6MWT will be repeated in the identical fashion shortly before the end of the camp session, at approximately the same time of day. Any child who becomes unusually fatigued during the modified 6MWT, will be encouraged to rest until he or she is ready to continue. A short standardized survey to measure self-concept will be given to the kidney campers and to control campers to be completed upon arrival and shortly prior to leaving camp using the Harter Self Perception Profile for Children (SPPC). Camp physical forms will be used to determine age, weight, and height for control campers and be directly measured for the kidney campers. STATISTICS The primary data collected will be the distance traveled on the 6MWT. Each child will serve as his/her own control for paired t-test analysis. Secondary data, which will emphasize the kidney campers, will be perceived exertion and self concept. In both groups, if possible, correlations will be drawn between activity levels prior to camp, performance on the 6MWT, and measurement of self-concept. Also, group analyses will be done with comparisons to previously published standard data. As this is a pilot project and little data exists on the activity levels of children with kidney disease and no similar study has ever been done, it is difficult to predict what changes in activity will be seen. Consequently power calculations are not provided. Similarly, most studies of exercise use periods considerably longer than 12 days, so it is possible that 12 days is insufficient to see a measureable change in the 6MWT. Although all campers in the bunk or village will be asked to participate in the 6MWT, only data from those campers whose families have provided consent and campers who have provided assent will be used for analysis. If sufficient non-kidney campers participate, data can be analyzed in a similar manner to measure the impact of the camp experience on their physical fitness and self-concept. In this situation, data regarding screen time pre camp as well as the pedometer measurements pre-camp may be instructive. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02803541
Study type Interventional
Source University of North Carolina, Chapel Hill
Contact
Status Completed
Phase N/A
Start date June 2016
Completion date July 2016

See also
  Status Clinical Trial Phase
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Terminated NCT04043026 - The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function
Completed NCT05318014 - Low-protein Formula Supplements in Chronic Kidney Disease N/A
Active, not recruiting NCT06071065 - Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients N/A
Completed NCT02878317 - Skin Autofluorescence as a Risk Marker in People Receiving Dialysis.
Not yet recruiting NCT06039254 - Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function Phase 1
Recruiting NCT03160326 - The QUALITY Vets Project: Muscle Quality and Kidney Disease
Withdrawn NCT02885545 - The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial Phase 4
Completed NCT02896309 - The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity N/A
Completed NCT02875886 - DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease Phase 4
Completed NCT02836574 - A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease Phase 2
Completed NCT02888171 - Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency N/A
Completed NCT02756520 - Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)
Active, not recruiting NCT02483039 - Nephrologist Follow-up Versus Usual Care After an Acute Kidney Injury Hospitalization N/A
Completed NCT02369549 - Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease Phase 3
Terminated NCT02543177 - Optimised Procedure in Patients With NSTEMI and CKD N/A
Completed NCT02992548 - Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease Phase 4
Recruiting NCT02205944 - Impact of Presurgical Exercise on Hemodialysis Fistula Outcomes N/A
Active, not recruiting NCT02231138 - Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease Phase 4